Pulmonary vascular resistance (PVR) is an important hemodynamic variable that affects prognosis and therapy in a wide range of cardiovascular and pulmonary conditions. We sought to determine whether a noninvasive estimate of PVR predicts adverse outcomes in patients with stable coronary artery disease. Using Doppler echocardiography we measured the estimated PVR (defined as the ratio of the tricuspid regurgitant velocity [TRV] to the velocity-time integral [VTI] of the right ventricular outflow tract [RVOT]) in 795 ambulatory patients with stable coronary artery disease. Participants were categorized by quartiles of the TRV/VTI RVOT ratio. Hazard ratios (HRs) and 95% confidence intervals were calculated for all-cause mortality, heart failure hospitalization, and adverse cardiovascular events (cardiovascular death, nonfatal myocardial infarction, or stroke). After 4.3 years of follow-up there were 161 deaths, 44 deaths from cardiovascular causes, 103 heart failure hospitalizations, and 120 adverse cardiovascular events. Compared with patients in the lowest TRV/ VTI RVOT quartile, those in the highest quartile were at increased risk of all-cause mortality (unadjusted HR 1.8, 95% confidence interval 1.3 to 2.5), heart failure hospitalization (unadjusted HR 2.9, 95% confidence interval 2.0 to 4.3), and adverse cardiovascular events (unadjusted HR 2.0, 95% confidence interval 1.4 to 2.9). After multivariate adjustment, patients in the highest quartile were at increased risk of heart failure hospitalizations (adjusted HR 2.5, 95% confidence interval 1.3 to 4.7). In conclusion, a noninvasive estimate of PVR (TRV/VTI RVOT ratio) predicts mortality, heart failure hospitalization, and adverse cardiovascular events in patients with stable coronary artery disease.Doppler echocardiography has achieved widespread use as a noninvasive means of estimating pulmonary artery pressure. 1 We previously demonstrated that an increase in Doppler-estimated pulmonary artery pressures predicts mortality and heart failure hospitalization in patients with stable coronary artery disease. 2 Because flow and pressure in the pulmonary circulation can be measured noninvasively, we hypothesized that a previously validated echocardiographic estimate of pulmonary vascular resistance (PVR), the ratio of tricuspid regurgitant velocity (TRV) to the velocity-time integral (VTI) of the right ventricular outflow tract (RVOT), predicts adverse cardiovascular events independently of established risk factors, and provides incremental prognostic value beyond that provided by pulmonary artery pressure in patients with stable coronary artery disease. 3 *Corresponding author: Tel: 617-642-8373; fax: 415-376-1175. rfarzanehfar@medicine.ucsf.edu (R. Farzaneh-Far
MethodsThe Heart and Soul Study is a prospective cohort study investigating the influence of psychosocial factors on cardiovascular events in outpatients with stable coronary artery disease. The enrollment process for the Heart and Soul Study has been previously described. 4 Eligible participan...